Koning, Frits

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut

Mesenchymal stem cell researchInflammatory Bowel Disease

Cited by 622

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

de Vries, N. L., van de Haar, J., Veninga, V., Chalabi, M., Ijsselsteijn, M. E., van der Ploeg, M., van den Bulk, J., Ruano, D., van den Berg, J. G., Haanen, J. B., et al. (2023) · Nature

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 311

Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor.

Foster, C. A., Yokozeki, H., Rappersberger, K., Koning, F., Volc-Platzer, B., Rieger, A., Coligan, J. E., Wolff, K., & Stingl, G. (1990) · The Journal of experimental medicine

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 182